Search - tctmd.com

Displaying 281 - 300 of 653

Sort: Relevancy | Date

Presentation TCT 2024

TCT 1405: A Challenging Case of Mitral Regurgitation With Severe Annular Calicium: Use of the AltaValve System for Transcatheter Mitral Valve Replacement

Presenter: DAVID ELISON

October 27, 2024

Presentation TCT 2024

TCT 88: Bioprosthetic Valve Fracture After Valve-in-Valve Transcatheter Mitral Valve Replacement Improves Transcatheter Heart Valve Expansion

Presenter: Akshay Kamath

October 27, 2024

Presentation TCT 2024

Transcatheter Mitral Valve Therapy - What Works, What Still Does Not and Why

Presenter: Yaron Almagor

October 27, 2024

Presentation TCT 2024

TCT 632: Trends in Outcomes of Elective Versus Non-Elective Transcatheter Edge-to-Edge Repair of Mitral Valve

Presenter: Muddasir Ashraf

October 27, 2024

Presentation TCT 2024

TCT 631: Outcomes in Patients With Major Postprocedural Bleeding After Transcatheter Edge-to-Edge Repair of the Mitral Valve

Presenter: Haroon Zubair

October 27, 2024

Presentation TCT 2024

TCT 629: NTproBNP Predicts Outcome in Patients Undergoing Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation

Presenter: Philipp von Stein

October 27, 2024

Presentation TCT 2024

TCT 141: Transcatheter Aortic-Valve Replacement (TAVR) Versus Surgical Aortic-Valve Replacement (SAVR) in Low-Risk Patients at Long Term Follow Up: Meta-Analysis of Randomized Controlled Trials

Presenter: Sunny Goel

October 27, 2024

Presentation TCT 2024

TCT 143: A Validated Risk Model for Acute Kidney Injury Prediction in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Charles Odenigbo

October 27, 2024

Presentation TCT 2024

TCT 628: Transcatheter Edge-to-Edge Repair in Patients With Acute Mitral Regurgitation Complicated by Cardiogenic Shock

Presenter: Roger Laham

October 27, 2024

Presentation TCT 2024

TCT 633: Impact of Nutritional Status on Transcatheter Edge-to-Edge Repair Outcomes in Mitral Regurgitation: Insights From a National Database Analysis

Presenter: Olayiwola Bolaji

October 27, 2024

Presentation TCT 2024

TCT 142: Time-Dependent Survival After Transcatheter Versus Surgical Aortic Valve Replacement: Results From the AUTHEARTVISIT Study

Presenter: Johann Auer

October 27, 2024

Presentation TCT 2024

TCT 140: Evaluating Outcomes of Percutaneous Coronary Intervention for Acute Coronary Syndrome in Patients With Prior Transcatheter Aortic Valve Implantation: A Retrospective Study

Presenter: Parth Desai

October 27, 2024

Presentation TCT 2024

My Perspective on an Ideal Transcatheter Tricuspid Valve Therapy

Presenter: Vlasis Ninios

October 27, 2024

Presentation TCT 2024

TCT 1406: Transcatheter Tricuspid Valve Replacement via Jugular Access Using Edwards Certitude System

Presenter: Prateek Madaan

October 27, 2024

Presentation TCT 2024

TCT 1386: Taking the High Road: A Challenging Transcatheter Tricuspid Valve Replacement

Presenter: moahemmd alkasab

October 27, 2024

Presentation TCT 2024

TCT 1569: Percutaneous Transcatheter Tricuspid Valve Replacement in a Patient With Previous Tricuspid Endocarditis

Presenter: Omar Abdul Jawad Altisent

October 27, 2024

Presentation TCT 2024

TCT 627: Sex-Specific Outcomes of Transcatheter Edge-to-Edge Repair in Degenerative Mitral Regurgitation: Results From the CLASP IID Trial

Presenter: Molly Szerlip

October 27, 2024

Presentation TCT 2024

TCT 623: Outcomes of Mitral Transcatheter Edge-to-Edge Repair in Patients With Mitral Valve Area Less Than 4cm2

Presenter: Chloe Kharsa

October 27, 2024

Presentation TCT 2024

Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry

Presenter: Francesco Pelliccia

October 27, 2024

Presentation TCT 2024

Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following Transcatheter Aortic Valve Replacement

Presenter: Josep Rodés-Cabau

October 27, 2024

Advertisement

TCT 1405: A Challenging Case of Mitral Regurgitation With Severe Annular Calicium: Use of the AltaValve System for Transcatheter Mitral Valve Replacement

TCT 88: Bioprosthetic Valve Fracture After Valve-in-Valve Transcatheter Mitral Valve Replacement Improves Transcatheter Heart Valve Expansion

Transcatheter Mitral Valve Therapy - What Works, What Still Does Not and Why

TCT 632: Trends in Outcomes of Elective Versus Non-Elective Transcatheter Edge-to-Edge Repair of Mitral Valve

TCT 631: Outcomes in Patients With Major Postprocedural Bleeding After Transcatheter Edge-to-Edge Repair of the Mitral Valve

TCT 629: NTproBNP Predicts Outcome in Patients Undergoing Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation

TCT 141: Transcatheter Aortic-Valve Replacement (TAVR) Versus Surgical Aortic-Valve Replacement (SAVR) in Low-Risk Patients at Long Term Follow Up: Meta-Analysis of Randomized Controlled Trials

TCT 143: A Validated Risk Model for Acute Kidney Injury Prediction in Patients Undergoing Transcatheter Aortic Valve Replacement

TCT 628: Transcatheter Edge-to-Edge Repair in Patients With Acute Mitral Regurgitation Complicated by Cardiogenic Shock

TCT 633: Impact of Nutritional Status on Transcatheter Edge-to-Edge Repair Outcomes in Mitral Regurgitation: Insights From a National Database Analysis

TCT 142: Time-Dependent Survival After Transcatheter Versus Surgical Aortic Valve Replacement: Results From the AUTHEARTVISIT Study

TCT 140: Evaluating Outcomes of Percutaneous Coronary Intervention for Acute Coronary Syndrome in Patients With Prior Transcatheter Aortic Valve Implantation: A Retrospective Study

My Perspective on an Ideal Transcatheter Tricuspid Valve Therapy

TCT 1406: Transcatheter Tricuspid Valve Replacement via Jugular Access Using Edwards Certitude System

TCT 1386: Taking the High Road: A Challenging Transcatheter Tricuspid Valve Replacement

TCT 1569: Percutaneous Transcatheter Tricuspid Valve Replacement in a Patient With Previous Tricuspid Endocarditis

TCT 627: Sex-Specific Outcomes of Transcatheter Edge-to-Edge Repair in Degenerative Mitral Regurgitation: Results From the CLASP IID Trial

TCT 623: Outcomes of Mitral Transcatheter Edge-to-Edge Repair in Patients With Mitral Valve Area Less Than 4cm2

Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry

Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following Transcatheter Aortic Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content